Cargando…
Frequency of New or Enlarging Lesions on MRI Outside of Clinical Attacks in Patients With MOG-Antibody–Associated Disease
BACKGROUND AND OBJECTIVE: To determine the frequency of new or enlarging T2-hyperintense or enhancing lesions outside of clinical attacks in myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) vs multiple sclerosis (MS) and aquaporin-4 antibody positive neuromyelitis optica spect...
Autores principales: | Syc-Mazurek, Stephanie B., Chen, John J., Morris, Pearse, Sechi, Elia, Mandrekar, Jaywant, Tillema, Jan-Mendelt, Lopez-Chiriboga, A. Sebastian, Lucchinetti, Claudia Francesca, Zalewski, Nicholas, Cacciaguerra, Laura, Buciuc, Marina, Krecke, Karl N., Messina, Steven Anthony, Bhatti, M. Tariq, Pittock, Sean J., Flanagan, Eoin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651461/ https://www.ncbi.nlm.nih.gov/pubmed/36175150 http://dx.doi.org/10.1212/WNL.0000000000201263 |
Ejemplares similares
-
Comparison of MRI Lesion Evolution in Different Central Nervous System Demyelinating Disorders
por: Sechi, Elia, et al.
Publicado: (2021) -
Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease
por: Valencia‐Sanchez, Cristina, et al.
Publicado: (2022) -
The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
por: Höftberger, Romana, et al.
Publicado: (2020) -
Population-based study of “no evident disease activity” in MS
por: Parks, Natalie E., et al.
Publicado: (2018) -
Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing
por: Sechi, Elia, et al.
Publicado: (2021)